Compression Therapy Market is expected to grow at a CAGR of 6.1 % by 2027

According to the most recent report on the global compression therapy market for the historical period 2017–2018 and the forecast period 2019–2027, rising sports injuries, an increase in the number of orthopedic surgeries, and a rapidly growing obese population drive global demand for compression therapy products. However, the lack of favorable reimbursement policies for vascular disease treatment with compression products would stifle market growth. Athletes and sportspeople frequently use compression products to relieve muscle pain, increase mobility, and improve athletic performance. Competitive, recreational, or compulsory (physical education) activities are the most common causes of sports injuries. High school athletes alone account for 2 million injuries, 50,000 doctor visits, and 30,000 hospitalizations in the United States each year, according to the Centers for Disease Control and Prevention (CDC).

According to the report, the global compression therapy market was worth US$ 3.2 billion in 2018 and is expected to grow at a CAGR of 6.1 percent between 2019 and.

As a result, health care professionals (chiropractors and physiotherapists) use these products extensively for both amateur and professional sports patients, as well as their regular clinic patients. As a result, an increase in the number of sports injuries and a growing preference among health care professionals are expected to drive uptake of compression therapy products during the forecast period.

Obese people are more likely to develop vascular diseases due to the pressure exerted by the body's weight on the skin and underlying organs. Obesity prevalence has more than doubled since 1980, according to the World Health Organization. According to the WHO, over 1.9 a billion adults aged 18 and up were reported to be overweight in 2014, with over 600 million of these adults being obese. Furthermore, it is estimated that in 2016, more than 35% of the total population was obese. This figure is expected to rise over the forecast period. As a result, the rise in the obese population increases the use of compression therapy products to prevent vascular diseases.

In recent years, unfavorable reimbursement policies have played a critical role in the compression therapy industry. The treatment of vascular diseases with compression therapy products is costly, requiring large sums of money for follow-ups and treatment monitoring. As a result, reimbursement is regarded as an essential component of the treatment. The Centers for Medicare and Medicaid Services (CMS) only reimburses patients who have completed a four-week trial of conservative therapy before deciding on an intermittent pump.

The global compression therapy market is highly fragmented, with numerous international and regional players.